Cardiovascular Biomarkers

Dear Colleagues,

Although well-known cardiovascular risk factors explain most of atherosclerotic risk and represent the first line of treatment (e.g., lipid lowering drugs), a significant residual risk for cardiovascular events remains. A number of new biomarkers belonging to pathophysiological events involved in the onset and progression of the atherosclerotic damage (e.g., belonging to the inflammatory, oxidative, prothrombotic, and metabolic pathways) are being continuously proposed, but currently not utilized in clinical practice. Each newly proposed biomarker must be evaluated in terms of its applicability to clinical practice (e.g., optimal cut-offs, standardization, ease of performing, costs, and value) as well as verified in specific patient cohorts to establish its significance in different clinical settings and identify patients that would benefit from its use.

We seek original research and reviews for this special issue which will focus on the role of molecules, biomarkers and pathways involved in the cardiovascular pathophysiology. Further data regarding methodological evaluation, clinical significance, ability to better stratify cardiovascular risk are also welcomed. The ultimate goal is to determine their significance as new additional/alternative therapeutic agents in order to refine and improve cardiovascular risk management.

Dr. Cristina Vassalle, Dr. Melania Gaggini and Dr. Francesca Gorini

Guest Editors

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.